Prognostic Value of Apparent Diffusion Coefficient (ADC) in Patients with Diffuse Gliomas

被引:0
|
作者
Busic, Marija [1 ]
Rumboldt, Zoran [2 ]
Cerina, Dora [3 ]
Busic, Zeljko [1 ]
Dolic, Kresimir [1 ,4 ,5 ]
机构
[1] Univ Hosp Split, Dept Diagnost & Intervent Radiol, Spinciceva 1, Split 21000, Croatia
[2] Univ Rijeka, Sch Med, Ul Brce Branchetta 20-1, Rijeka 51000, Croatia
[3] Univ Hosp Split, Dept Oncol, Spinciceva 1, Split 21000, Croatia
[4] Univ Split, Sch Med, Soltanska 1, Split 21000, Croatia
[5] Univ Dept Hlth Studies, Univ Split, Ul Rudera Boskovica 35, Split 21000, Croatia
关键词
glioma; magnetic resonance imaging; apparent diffusion coefficient; biomarkers; APPEARING WHITE-MATTER; PREOPERATIVE EVALUATION; GRADE; INVASION; ASTROCYTOMAS; SPECTROSCOPY; RADIOTHERAPY;
D O I
10.3390/cancers16040681
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary This retrospective study aimed to analyze ADC values in the tissue surrounding enhancing gliomas and in the normal-appearing white matter. The goal was to find potential correlations of these values with treatment response and survival of patients. Patients, divided into short and long survival groups, underwent stereotactic biopsy or maximal surgical resection, followed by concomitant radio-chemotherapy. Baseline and follow-up MRI scans revealed significant differences in NAWM ADC values between the groups. Overall, the study suggests that ADC values in NAWM could serve as a prognostic biomarker for diffuse glioma patients.Abstract This study aimed to evaluate potential posttreatment changes in ADC values within the tissue surrounding the enhancing lesion, particularly in areas not exhibiting MRI characteristics of involvement. Additionally, the objective was to investigate the correlations among ADC values, treatment response, and survival outcomes in individuals diagnosed with gliomas. This retrospective study included a total of 49 patients that underwent either stereotactic biopsy or maximal surgical resection. Histologically confirmed as Grade III or IV gliomas, all cases adhered to the 2016 and 2021 WHO classifications, with subsequent radio-chemotherapy administered post-surgery. Patients were divided into two groups: short and long survival groups. Baseline and follow-up MRI scans were obtained on a 1.5 T MRI scanner. Two ROI circles were positioned near the enhancing area, one ROI in the NAWM ipsilateral to the neoplasm and another symmetrically in the contralateral hemisphere on ADC maps. At follow-up there was a significant difference in both ipsilateral and contralateral NAWM between the two groups, -0.0857 (p = 0.004) and -0.0607 (p = 0.037), respectively. There was a weak negative correlation between survival and ADC values in ipsilateral and contralateral NAWM at the baseline with the correlation coefficient -0.328 (p = 0.02) and -0.302 (p = 0.04), respectively. The correlation was stronger at the follow-up. The findings indicate that ADC values in normal-appearing white matter (NAWM) may function as a prognostic biomarker in patients with diffuse gliomas.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Value of diffusion weighted imaging (DWI) and apparent diffusion coefficient factor (ADC) calculation in differentiation of solid breast lesions
    Osman, Ahmed M.
    Shebrya, Naglaa H.
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2016, 47 (01): : 363 - 371
  • [42] Assessment of apparent diffusion coefficient value as prognostic factor for renal cell carcinoma aggressiveness
    Medhat Ibraheem Mohammad Ahmad
    Mohammad Sabr
    Eman Roshy
    Egyptian Journal of Radiology and Nuclear Medicine, 50
  • [43] GLIOBLASTOMA TREATED WITH POSTOPERATIVE RADIOCHEMOTHERAPY: PROGNOSTIC VALUE OF APPARENT DIFFUSION COEFFICIENT AT MR IMAGING
    Yamasaki, Fumiyuki
    Sugiyama, Kazuhiko
    Kajiwara, Yoshinori
    Saito, Taiichi
    Hidaka, Toshikazu
    Nishimoto, Takeshi
    Watanabe, Yosuke
    Kurisu, Kaoru
    NEURO-ONCOLOGY, 2009, 11 (06) : 934 - 934
  • [44] Assessment of apparent diffusion coefficient value as prognostic factor for renal cell carcinoma aggressiveness
    Ahmad, Medhat Ibraheem Mohammad
    Sabr, Mohammad
    Roshy, Eman
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2019, 50 (01):
  • [45] Deep learning based apparent diffusion coefficient map generation from multi-parametric MR images for patients with diffuse gliomas
    Eidex, Zach
    Safari, Mojtaba
    Wynne, Jacob
    Qiu, Richard L. J.
    Wang, Tonghe
    Hernandez, David Viar
    Shu, Hui-Kuo
    Mao, Hui
    Yang, Xiaofeng
    MEDICAL PHYSICS, 2025, 52 (02) : 847 - 855
  • [46] Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors
    Razek, Ahmed Abdel Khalek Abdel
    Gaballa, Gada
    Denewer, Adel
    Nada, Nadia
    NMR IN BIOMEDICINE, 2010, 23 (06) : 619 - 623
  • [47] Diffusion-Weighted Imaging of Breast Cancer: Correlation of the Apparent Diffusion Coefficient Value with Prognostic Factors
    Kim, Sung Hun
    Cha, Eun Suk
    Kim, Hyeon Sook
    Kang, Bong Joo
    Choi, Jae Jeong
    Jung, Ji Han
    Park, Yong Gyu
    Suh, Young Jin
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 30 (03) : 615 - 620
  • [48] Siglec-15 expression in diffuse gliomas and its correlation with MRI morphologic features and apparent diffusion coefficient
    Chen, Quan
    Wang, Chunhua
    Geng, Yingqian
    Zheng, Wanyi
    Chen, Zhen
    Jiang, Rifeng
    Hu, Xiaomei
    ACTA RADIOLOGICA, 2024, 65 (11) : 1401 - 1410
  • [49] Validity of apparent diffusion coefficient (ADC) value in diagnosis and follow-up of multiple sclerosis patients in different clinical subtypes
    Mohammed, Faten Fawzy
    Ismail, Mohamed Hamdy
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2018, 49 (04): : 1103 - 1109
  • [50] COMBINATION OF APPARENT DIFFUSION COEFFICIENT AND FET PET COMPARED WITH STANDARD IMAGING FOR QUANTITATIVE TUMOR PRESENCE IN DIFFUSE GLIOMAS
    Joe, K. Tjong Tjin
    Wesseling, P.
    Barkhof, F.
    Belien, J.
    Yaqub, M. M.
    Pouwels, P. J. W.
    Verhaak, R.
    Reijneveld, J. C.
    Rozemuller, A. J. M.
    Vandertop, W. P.
    Boellaard, R.
    Barthel, F.
    Hamer, P. C. de Witt
    van de Giessen, E.
    Verburg, N.
    NEURO-ONCOLOGY, 2023, 25